Company Monitoring Page for Gilead-Sciences

latest headlines for company on cafepharma

Gilead's long-awaited remdesivir price is $3,120, in line with watchdog estimates
Fierce Pharma
Mon, 06/29/20 - 10:46 am
Tags:
drug pricing, Gilead Sciences, COVID-19, remdesivir
Price for Gilead's COVID-19 drug should shrink if cheap steroid widely used, ICER says
BioPharma Dive
Thu, 06/25/20 - 07:25 pm
Tags:
Gilead Sciences, remdesivir, ICER, drug pricing, steriod
Gilead pens $1.5B buyout option deal for Pionyr
Fierce Biotech
Tue, 06/23/20 - 10:50 am
Tags:
Gilead Sciences, Pionyr, M&A, immuno-oncology
Gilead to Test Inhaled Form of Remdesivir in COVID-19 Starting in August
BioSpace
Mon, 06/22/20 - 08:43 pm
Tags:
Gilead Sciences, remdesivir, inhaled drugs, COVID-19, pandemic, clinical trials
Does Gilead Have a Cure for the Coronavirus?
Motley Fool
Sun, 06/21/20 - 11:02 pm
Tags:
Gilead Sciences, remdesivir, COVID-19
Gilead will test remdesivir in children with COVID-19
Pharmaforum
Thu, 06/18/20 - 10:34 am
Tags:
Gilead Sciences, remdesivir, pediatric, clinical trials, COVID-19
Gilead sees better days ahead for CAR-T therapy Yescarta with Amsterdam manufacturing hub online
Fierce Pharma
Mon, 06/15/20 - 11:08 pm
Tags:
Gilead Sciences, CAR-T, Yescarta, Amsterdam, drug manufacturing
Could Gilead Sciences Have an HIV Cure Waiting in the Wings?
Motley Fool
Sun, 06/14/20 - 10:49 pm
Tags:
Gilead Sciences, HIV, bNab
AstraZeneca's Acquisition of Gilead Would Create a COVID-19 Colossus -- but Don't Bet on Seeing It Happen
Motley Fool
Tue, 06/9/20 - 12:19 pm
Tags:
AstraZeneca, Gilead Sciences, M&A, COVID-19
Gilead files remdesivir for EU approval, with a verdict possible “in weeks”
Pharmaforum
Tue, 06/9/20 - 10:36 am
Tags:
EMA, Europe, Gilead Sciences, remdesivir, COVID-19
Gilead builds case for filgotinib in active psoriatic arthritis
Fierce Biotech
Mon, 06/8/20 - 10:38 am
Tags:
Gilead Sciences, Galapagos, filgotinib, clinical trials, psoriatic arthritis
AstraZeneca reportedly eyed a merger with Gilead. But does 'Gileaz' make sense?
Fierce Pharma
Mon, 06/8/20 - 10:33 am
Tags:
M&A, Gilead Sciences, AstraZeneca
AstraZeneca Approaches Gilead About Potential Merger
Bloomberg
Sun, 06/7/20 - 10:53 pm
Tags:
AstraZeneca, Gilead Sciences, M&A
Could Gilead's COVID-19 Drug Make $7 Billion Per Year?
Motley Fool
Sun, 06/7/20 - 10:25 pm
Tags:
Gilead Sciences, COVID-19, remdesivir
Gilead shows durability of filgotinib ahead of face-off with AbbVie
Fierce Biotech
Thu, 06/4/20 - 11:00 am
Tags:
Gilead Sciences, Galapagos, clinical trials, filgotinib, rheumatoid arthritis
Gilead's next step on coronavirus: inhaled remdesivir, other easier-to-use versions
Reuters
Tue, 06/2/20 - 11:19 pm
Tags:
Gilead Sciences, drug development, remdesivir, COVID-19
Stanford researcher Genovese joins Gilead to lead NASH, arthritis programs
Fierce Biotech
Tue, 06/2/20 - 10:46 am
Tags:
Gilead Sciences, Mark Genovese, NASH, arthritis
Gilead’s remdesivir shows some benefit in patients with moderate Covid-19, new data show
Stat
Mon, 06/1/20 - 10:32 am
Tags:
Gilead Sciences, remdesivir, COVID-19
Gilead trumpets data with newly-bought magrolimab in blood cancers
Pharmaforum
Sun, 05/31/20 - 11:53 pm
Tags:
Gilead Sciences, ASCO 2020, Forty Seven, magrolimab, M&A, MDS
Gilead’s newly bought immunotherapy drug scores at ASCO
MedCity News
Fri, 05/29/20 - 12:30 pm
Tags:
Gilead Sciences, ASCO 2020, magrolimab, clinical trials, AML, MDS

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.